Cellectis S.A. (EPA:ALCLS)
3.430
-0.042 (-1.21%)
Apr 28, 2026, 5:35 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €248.99 million as of April 28, 2026. Its market cap has increased by 156.21% in one year.
Market Cap
248.99M
Enterprise Value
147.05M
Revenue
67.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.43
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 248.99M, an increase of 147.52%. That is a compound annual growth rate of 4.83%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 207.33M |
| Sensorion | 194.82M |
| Valneva SE | 402.24M |
| Genfit | 407.33M |
| ABIONYX Pharma | 127.00M |
| Innate Pharma | 105.09M |
| MaaT Pharma | 102.89M |
| Adocia | 90.87M |